Stay updated on Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page
- Check2 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected content, indicating restricted access to the study details. The page shows a standard error layout, with the study content effectively unavailable.SummaryDifference18%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates a new revision of the page content and implies minor updates to the document.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.6.5 appears on the page, indicating an update to the study record page; several legacy footer items and indexing terms were removed, reflecting a structural update rather than substantive content changes.SummaryDifference17%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor platform/template update. No visible changes to content or user-facing features are indicated by this revision.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now shows revision v3.6.3, replacing the previous v3.6.2. This indicates an updated page build or deployment, not a change to the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page now shows revision v3.6.2 instead of v3.6.0, signaling a small page update. This likely reflects a minor backend or formatting adjustment rather than a substantive change to the study information.SummaryDifference0.1%

Stay in the know with updates to Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.